Localization of radiolabeled anti-CEA antibody in subcutaneous and intrahepatic colorectal xenografts: influence of tumor size and location within host organ on antibody uptake

Nuclear Medicine and Biology

Volumn 36, Issue 8, 2009, Pages 883-894

  Dearling, Jason L J ^a   Flynn, Aiden A ^a   Qureshi, Uzma ^a   Whiting, Stephen ^b   Boxer, Geoffrey M ^a   Green, Alan ^a   Begent, Richard H J ^a   Pedley, R Barbara ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Metastases; microdistribution; Radioimmunotherapy

Indexed keywords

MONOCLONAL ANTIBODY A5B7 I 125; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BODY WEIGHT; COLORECTAL CANCER; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG RETENTION; IN VIVO STUDY; ISOTOPE LABELING; LIVER FUNCTION TEST; LIVER METASTASIS; MOUSE; NONHUMAN; QUANTITATIVE ANALYSIS; RADIOIMMUNOASSAY; RADIOIMMUNOTHERAPY; SURVIVAL TIME; TUMOR LOCALIZATION; TUMOR VOLUME; TUMOR XENOGRAFT;

ANIMALS; ANTIBODIES, MONOCLONAL; CARCINOEMBRYONIC ANTIGEN; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; LIVER NEOPLASMS; METABOLIC CLEARANCE RATE; MICE; RADIOPHARMACEUTICALS; TISSUE DISTRIBUTION;

EID: 70350217300     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2009.07.003     Document Type: Article

References (33)

1. Dearling J.L., and Pedley R.B. Technological advances in radioimmunotherapy. Clin Oncol (R Coll Radiol) 19 (2007) 457-469
2. Press O.W., Eary J.F., Appelbaum F.R., et al. Phase II trial of I-131 B1 (anti-CD20) antibody therapy with autologous stem-cell transplantation for relapsed B-cell lymphomas. Lancet 346 (1995) 336-340
3. Behr T.M., Liersch T., Greiner-Bechert L., et al. Radioimmunotherapy of small-volume disease of metastatic colorectal cancer. Cancer 94 (2002) 1373-1381
4. 131I-Labetuzumab after salvage resection of colorectal metastases in the liver: five-year safety and efficacy results. J Clin Oncol 23 (2005) 6763-6770
5. 131I-Labetuzumab after salvage resection of colorectal liver metastases: Comparison of outcome to a contemporaneous control group. Ann Surg Oncol 14 (2007) 2577-2590
6. Paget S. The distribution of secondary growths in cancer of the breast. Lancet 133 3421 (1989) 571-573
7. Tom B.H., Rutzky L.P., Jakstys M.M., Oyashu R., Kaye C.I., and Kahan B.D. Human colonic adenocarcinoma cell. I. Establishment and description of a new line. In Vitro 12 (1976) 180-191
8. Harwood P.J., Britton D.W., Southall P.J., Boxer G.M., Rawlins G., and Rogers G.T. Mapping epitope characteristics on carcinoembryonic antigen. Br J Cancer 54 (1986) 75-82
9. Greenwood F.C., and Hunter W.M. The preparation of 131-I-labelled human growth hormone of high specific radioactivity. Biochem J 89 (1963) 116-123
10. Flynn A.A., Green A.J., Boxer G., Pedley R.B., and Begent R.H.J. A comparison of image registration techniques for the correlation of radiolabelled antibody distribution with tumor morphology. Phys Med Biol 44 (1999) 151-159
11. Mies G., Niebuhr I., and Hossmann K.A. Simultaneous measurement of blood flow and glucose metabolism by autoradiographic techniques. Stroke 12 (1981) 581-588
12. Sato N., Saga T., Sakahara H., et al. Intratumoral distribution of radiolabeled antibody and radioimmunotherapy in experimental liver metastases model of nude mouse. J Nucl Med 40 (1999) 685-692
13. Hagan P.L., Halpern S.E., Dillman R.O., et al. Tumor size: effect on monoclonal antibody uptake in tumor models. J Nucl Med 27 (1986) 422-427
14. Pedley R.B., Boden J., Keep P.A., Harwood P.J., Green A.J., and Rogers G.T. Relationship between tumour size and uptake of radiolabelled anti-CEA in a colon tumour xenograft. Eur J Nucl Med 13 (1987) 197-202
15. Li X.F., Kinuya S., Yokoyama K., et al. Benefits of combined radioimmunotherapy and anti-angiogenic therapy in a liver metastasis model of human colon cancer cells. Eur J Nucl Med 29 (2002) 1669-1674
16. 186Re-labeled monoclonal antibody to treat liver metastases of colon cancer cells in nude mice. Cancer Biother Radiopharm 17 (2002) 681-687
17. Williams L.E., Duda R.B., Proffitt R.T., et al. Tumor uptake as a function of tumor mass: A mathematical model. J Nucl Med 29 (1988) 103-109
18. Fidorova E.F., El-Emir E., Boxer G.M., et al. Microdistribution of targeted, fluorescently labeled anti-carcinoembryonic antigen antibody in metastatic colorectal cancer: implications for radioimmunotherapy. Clin Cancer Res 14 (2008) 2639-2646
19. Vogel C.A., Galmiche M.C., Westermann P., et al. Carcinoembryonic antigen expression, antibody localisation and immunophotodetection of human colon cancer liver metastases in nude mice: A model for radioimmunotherapy. Int J Cancer 67 (1996) 294-302
20. El-Emir E., Qureshi U., Dearling J.L., et al. Predicting response to radioimmunotherapy from the tumor microenvironment of colorectal carcinomas. Cancer Research 67 24 (2007) 11896-11905
21. Dearling J.L., Qureshi U., Begent R.H., and Pedley R.B. Combining radioimmunotherapy with antihypoxia therapy 2-deoxy-d-glucose results in reduction of therapeutic efficacy. Clin Cancer Res 13 (2007) 1903-1910
22. 213Bi-conjugated monoclonal antibody. Clin Cancer Res 11 19S (2005) 7070s-7074s
23. Quayle J.B. Ability of CEA blood levels to reflect tumour burden: a study in a human xenograft model. Br J Cancer 46 (1982) 220-227
24. Pedley R.B., Boden J.A., Boden R.W., Green A., Boxer G.M., and Bagshawe K.D. The effect of serum CEA on the distribution and clearance of anti-CEA antibody in a pancreatic tumour xenograft model. Br J Cancer 60 (1989) 549-554
25. Mendelsohn M.L., and Bodansky O. The value of liver-function tests in the diagnosis of intrahepatic metastases in the nonicteric cancer patient. Cancer 5 (1952) 1-8
26. Tartter P.I., Slater G., Gelernt I., and Aufses A.H. Screening for liver metastases from colorectal cancer with carcinoembryonic antigen and alkaline phosphatase. Ann Surg 193 (1981) 357-360
27. Kaiserman I., Amer R., and Pe'er J. Liver function tests in metastatic uveal melanoma. Am J Ophthalmol 137 (2004) 236-243
28. Rocklin M.S., Senagore A.J., and Talbott T.M. Role of carcinoembryonic antigen and liver function tests in the detection of recurrent colorectal carcinoma. Dis Colon Rectum 34 (1991) 794-797
29. Ottmar M.D., Gonda R.L., Leithauser K.J., and Gutierrez O.H. Liver function tests in patients with computed tomography demonstrated hepatic metastases. Gastrointest Radiol 14 (1989) 55-58
30. Wyld L., Gutteridge E., Pinder S., et al. Prognostic factors for patients with hepatic metastases from breast cancer. Br J Cancer 89 (2003) 284-290
31. Tibbetts L.M., Doremus C.M., Tzanakakis G.N., and Vezeridis M.P. Liver metastases with 10 human colon carcinoma cell lines in nude mice and association with carcinoembryonic antigen production. Cancer 71 (1993) 315-321
32. Saga T., Neumann R.D., Heya T., et al. Targeting cancer micrometastases with monoclonal antibodies: a binding site barrier. Proc Natl Acad Sci U S A 92 (1995) 899-9003
33. Tanaka S., Kitamura T., Fujita M., Nakanishi K., and Okuda S. Color Doppler flow imaging of liver tumors. AJR 154 (1990) 509-514